During a 4-year period, 9465 specimens for blood culture were obtained from 11,911 highly febrile, otherwise healthy young children. Of these specimens, 87 (0.9%) yielded nonpathogens and were considered to be falsepositive blood culture results (FPBCRs). Seventy-two of the patients who provided these specimens were treated on an outpatient basis (resulting in $10,821 in treatment charges), and 7 were admitted to the hospital (resulting in $16,200 in charges) as a result of the FPBCRs. Studies performed during follow-up included a second blood culture (21 patients), complete blood cell count (11), urine analysis and culture (5), lumbar puncture (3), and chest radiography (3). Only a small minority of patients were hospitalized or underwent invasive procedures. The charges associated with FPBCRs are very small in comparison to the initial charges of culturing specimens obtained from children considered to be at risk. Concern about the consequences of FPBCRs should not deter clinicians from performing indicated cultures for children who potentially have bacteremia.
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The evaluation of febrile children, aged 3-36 months, who have no identifiable focus of infection and who appear to be healthy has been the subject of much debate [1] [2] [3] . Physical examination alone is insufficient to identify children in this age group who have serious bacterial infections, which primarily occur in patients with temperatures of у39ЊC. Some authors, therefore, have recommended performing a blood culture as part of the evaluation of these highly febrile children, in an attempt to identify those with bacteremia [4] . However, among healthy-appearing febrile children, the use of immunization against Haemophilus influenzae type b (Hib) has reduced the rate of true-positive culture results to levels that are lower (1.6%) [5] than those observed at the time these recommendations were in-itially made. In addition, blood cultures may also yield nonpathogens as a result of contamination, thereby resulting in unnecessary testing and therapy, since a definitive distinction between pathogens and nonpathogens generally is not available at the time of clinical reevaluation [6] .
When the report of a positive blood culture result is first received, physicians are faced with the dilemma of how to best evaluate the usually healthy-appearing child who potentially has bacteremia. Some of these young patients undergo additional testing and treatment. Cost-effectiveness analyses of strategies used in the evaluation of young children who are highly febrile have not included the cost of false-positive blood culture results (FPBCRs). The purpose of this study was to describe the clinical and financial consequences of FPBCRs in highly febrile children aged 3-36 months.
METHODS
A retrospective review of the microbiology and medical records at a large urban children's hospital (Children's Hospital, Boston) was performed. In addition, records maintained by the primary care physician were also obtained for abstraction of data regarding follow-up management. All patients who were treated in the emergency department (ED) from 1 January 1993 through 31 December 1996 were considered for inclusion in the study if they were aged 3-36 months and had a rectal temperature of у39ЊC at the time of triage. We excluded patients who (1) were admitted to the hospital at the time of the initial visit; (2) were given (by the ED) an initial International Classification of Diseases, 9th Revision, discharge diagnosis that indicated the presence of a focal bacterial infection other than otitis media (e.g., pneumonia, abscess, cellulitis, meningitis, sinusitis, osteomyelitis, pyelonephritis, lymphadenitis, cholangitis, mastoiditis, impetigo, scarlet fever, streptococcal pharyngitis, or urinary tract infection); (3) were discharged with a diagnosis of a specific viral infection (e.g., croup, bronchiolitis, varicella, Coxsackie virus, herpangina, or stomatitis; or (4) were known to have a chronic illness or immunodeficiency (e.g., leukemia, agranulocytosis, aplastic anemia, arteritis, renal transplant, congenital heart disease, Kawasaki disease, nephrotic syndrome, or sickle cell disease) that would alter the approach to febrile illness. Laboratory tests were performed as part of the ED visit, in accordance with the department's standard guidelines for evaluation of febrile patients aged 3-36 months, and included a blood culture and a complete blood cell count. Children with otitis media were included because previous publications have documented a similar rate of bacteremia, regardless of the presence of otitis media [7] .
Blood for culture was drawn by nurses, physicians, or supervised medical students. Standard protocol required the use of 3 separate clean preparation pads that were saturated with 70% isopropyl alcohol for skin preparation [8] . The specimens were immediately placed into Bactec Peds Plus medium or a Bactec Peds Plus/F medium bottle, and they were analyzed by use of the Bactec 9240 continuous-monitoring system (Becton Dickinson).
Bacteria that were considered to be pathogenic included Streptococcus pyogenes, group B streptococci, Haemophilus influenzae type b, Neisseria meningitidis, Salmonella species, Staphylococcus aureus, and Streptococcus pneumoniae. All other isolated organisms were considered to be nonpathogens (in FPBCRs).
Primary care givers, if documented, were contacted as soon as blood cultures yielded a pathogen. Children who were seen during follow-up by their primary care givers were referred to the ED for further testing and consideration for admission if they appeared to be ill or continued to be febrile. For children with no documented primary care giver, the family was contacted directly about the positive blood culture result and was urged to return with the patient to the ED for reevaluation.
The decision to hospitalize patients was left to the discretion of the treating physician in the ED.
Data from follow-up visits, including information about additional or repeated laboratory testing, invasive procedures (e.g., lumbar puncture), hospitalization, and antibiotic use, were obtained either by review of the hospital record (for those patients who were reevaluated in the ED) or by review of the patient record maintained by the primary care provider.
The financial impact of follow-up evaluation was examined on the basis of charges rather than costs. These charges reflect actual dollar amounts (in US dollars) at the time of the study and were not adjusted for inflation. At the time of investigation, costs (in US dollars) at our institution were ∼0.7 times greater than charges.
RESULTS
There were 199,868 patient visits to the ED from 1 January 1993 through 31 December 1996. Children who were aged 3-36 months accounted for 70,142 (35%) of these encounters. No temperature was recorded for 2193 children (3%), and these patients were excluded from the study. Of the remaining patients, 15,912 (23%) had a temperature of у39ЊC at the time of triage. After exclusion of patients on the basis of the aforementioned criteria, 11,908 patients remained eligible for the study; blood samples for culture were obtained from 9465 patients (79%), of whom 242 (2.6%) had a single organism isolated from culture. For 155 (1.6%) of the 9465 patients, cultures yielded pathogens; 87 cultures (0.9%) yielded nonpathogens that were considered to be the result of contamination (in FPBCRs; table 1). Complete follow-up information was available for 79 (91%) of 87 patients with FPBCRs. Forty-eight (61%) of the 79 were seen during follow-up by the primary care provider alone, 25 (32%) were seen during follow-up for FPBCRs in the ED alone, and 6 (7%) were seen during follow-up with the primary care provider, who then referred them to the ED. Reevaluation of all 79 patients occurred within 48 h of the initial visit and performance of blood culture.
Viral syndrome was the only discharge diagnosis for 19 patients with FPBCRs. In addition to viral syndrome, review of the medical records revealed secondary diagnoses that included otitis media (18 patients), varicella (5), gastroenteritis (3), and bronchiolitis (2) . (The children with varicella and bronchiolitis had not had these discharge diagnoses coded and therefore met the study's inclusion criteria.) None of the patients who were followed up by the primary care provider alone had laboratory studies performed a second time. Of the patients who were reevaluated by their primary care providers, 32 (67%) had no antibiotics prescribed. Twelve (25%) of the patients who were seen by the primary care provider continued receiving a course of amoxicillin, 1 (2%) received a dose of im ceftriaxone, and 3 (6%) started receiving amoxicillin/clavulanate.
For the 31 patients who were evaluated in the ED during follow-up (25 were seen only in the ED, and 6 were evaluated by the primary care physician initially and then were referred to the ED), studies performed at that time included a second blood culture (21 patients), complete blood cell count (11), urine analysis and culture (5), lumbar puncture (3), and chest radiography (3). Antibiotic therapy was initiated or changed for 9 (29%) of 31 children who were reevaluated in the ED. Seven percent of the children were seen by the primary care provider for follow-up and were referred to the ED for additional evaluation. The charges associated with reevaluation in the ED, including laboratory procedures and initial antibiotic treatment, are summarized in table 2. Table 3 summarizes the inpatient charges for the 7 patients who were admitted as a direct consequence of FPBCRs. The diagnosis at admission was bacteremia for all 7 patients.
DISCUSSION
Healthy-appearing febrile children, aged 3-36 months, who have temperatures of у39ЊC are known to be at risk for serious illness [9, 10] . Untreated bacteremia may result in such complications as meningitis, pneumonia, septic arthritis, osteomyelitis, and purulent pericarditis [10] . The clinical identification of bacteremia ultimately relies on the definitive identification of pathogenic organisms in the blood, but a presumptive diagnosis may be made on the basis of the initial results of Gram stain and quellung reaction, when available. Nonetheless, when managing these cases, physicians are faced with difficult management decisions pending final identification of organisms.
Our findings have several clinical implications for physicians who treat febrile children, particularly those who are being reevaluated for a positive blood culture result. These implications are as follows:
1. The rate of FPBCRs in this population is much lower than that previously reported. Generally, a rate of у3.6% has been described, but in our ED, where we encourage the use of 3 isopropyl alcohol pads for skin preparation, the rate of FPBCRs was only 0.9%.
2. Using only initial Gram stain and quellung reaction findings (when appropriate) in combination with phone contact or clinical reevaluation, clinicians were able to appropriately manage the majority of these cases on an outpatient basis.
3. Some children undergo additional testing, including lumbar puncture, and some are hospitalized as a result of the FPBCRs. The $32,230 in charges that results from follow-up of patients with FPBCRs is small in comparison with the $719,340 in charges that is associated with the routine processing of the initial cultures for the 9465 febrile children in this study. This translates to an average of $3.40 ($32,230 Ϭ ) in additional per-patient charges that are incurred as a 9465 result of the FPBCRs.
4. These costs can be included in future cost-effectiveness analyses of treatment strategies for febrile young children.
CONCLUSIONS
We found a low rate of FPBCRs (0.9%) in our study. However, the organisms that were recovered from 36% of blood cultures that yielded growth were found to be contaminants. The charges that were associated with follow-up of children with FPBCRs added a mean of $3.40 in charges per culture obtained and therefore were insignificant in relation to the charges associated with the initial evaluation of young children with fever. Decisions about performing blood cultures should be based on the risk of true-positive culture results and on the usefulness of this information, rather than on fears of additional costs associated with FPBCRs.
